Short answer: Some people do notice more hair shedding after starting a GLP-1 medication such as Ozempic, Wegovy, Mounjaro or Zepbound. In clinical trials, hair loss was reported in about 3 to 5 in 100 people on the weight-loss doses, compared with about 1 in 100 on placebo. The most likely cause is the rapid weight loss itself, which can trigger a temporary type of shedding called telogen effluvium. For most people it settles within several months and the hair grows back. If shedding is patchy, lasts longer than about six months, or reveals a thinning pattern, it’s worth having your scalp assessed.
More and more of the men and women we see at Dr. Bobby’s clinic in Calgary are using GLP-1 medications for weight loss or diabetes. A common worry we hear is, “My weight is finally coming down, so why is my hair coming out?” In this article, we walk you through what the research shows, why the shedding happens, and how we approach it so you can protect your hair while you work on your health.
Which GLP-1 medications are used in Canada?
GLP-1 medications mimic a gut hormone that lowers blood sugar and reduces appetite. In Canada:
- Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are approved by Health Canada for long-term weight management.
- Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved for type 2 diabetes, although many people also lose weight on them.
The medication in Ozempic and Wegovy is the same, at different doses, and so is the medication in Mounjaro and Zepbound.
How common is hair loss on Ozempic, Wegovy, Mounjaro or Zepbound?
The clearest numbers come from the Canadian product monographs for the weight-loss products:
| Medication | Hair loss in trials | Placebo |
|---|---|---|
| Wegovy (semaglutide 2.4 mg) | 3.3% | 1.4% |
| Zepbound (tirzepatide 5, 10 or 15 mg) | 4.2% to 5.1% | 0.8% |
Two details stand out. In the Wegovy trials, hair loss was reported more often in people who lost 20% or more of their body weight than in those who lost less (5.3% vs 2.5%). In the Zepbound trials, every hair loss event was mild or moderate, and the U.S. label notes that it was associated with weight reduction and reported more often in women than in men.
For the diabetes versions, Ozempic and Mounjaro, hair loss isn’t listed as a common trial side effect. Between December 2024 and May 2025, the U.S. Food and Drug Administration added alopecia to the post-marketing section of their labels. That means it was reported after approval, but how often it happens is unknown.
Large studies of health records published in 2025 and 2026 have also found that people taking GLP-1 medications are diagnosed with hair loss somewhat more often than similar people on other medications. The absolute risk is still low, and these studies can’t tell whether the medication or the weight loss is responsible.
Why do GLP-1 medications cause hair shedding?
The leading explanation is telogen effluvium, a temporary shift of many hairs into the resting and shedding phase at the same time. It’s the same kind of shedding people notice after surgery, illness, childbirth or a crash diet.
Rapid weight loss is a known trigger. The American Academy of Dermatology lists losing 20 pounds or more as one, and notes that eating much less on these medications can leave the body short of the protein, vitamins and minerals hair needs to grow. Researchers haven’t ruled out a direct effect of the medication on hair follicles, but that hasn’t been shown.
When does the shedding start, and does the hair grow back?
Telogen effluvium usually starts about two to four months after the trigger, so many people notice it a few months into their weight loss rather than right after the first dose. You may see more hair on your pillow, in the shower drain or in your brush, and your ponytail or overall density may feel thinner.
The good news is that the follicles aren’t damaged. Shedding typically settles within about three to six months once your weight and eating stabilize, and the American Academy of Dermatology notes that hair tends to regain its normal fullness within six to nine months. According to the British Association of Dermatologists, shedding that continues past six months is considered chronic, and it deserves a closer look.
Can a GLP-1 medication reveal pattern hair loss?
Sometimes. Shedding can make an existing genetic thinning pattern (androgenetic alopecia) more noticeable, such as a receding hairline, a thinning crown, or a widening part. Some recent observational studies, including a 2025 analysis of U.S. health records, have reported more pattern hair loss diagnoses in people on these medications. The evidence is still early, and it may reflect shedding unmasking a pattern that was already there.
This is where an accurate diagnosis matters. At our clinic, Dr. Bobby uses trichoscopy, a magnified look at the scalp, to tell the difference. Shedding tends to affect hairs of normal thickness across the whole scalp. Pattern hair loss shows miniaturized, finer hairs in typical areas. The two need different plans.
How can I protect my hair while taking a GLP-1 medication?
Don’t stop or change your medication without talking to the doctor who prescribed it. These steps may help:
- Eat enough protein. A 2025 joint nutrition advisory for people on GLP-1 therapy notes that targets of 1.2 to 1.6 g of protein per kilogram per day have been proposed during active weight loss, and suggests a simpler target of about 80 to 120 g a day.
- Aim for steady, not crash, weight loss. Dermatologists suggest people prone to hair loss lose weight more slowly. Ask your prescriber whether your dose schedule suits you.
- Check for deficiencies. Low iron stores and thyroid problems can cause or prolong shedding. Blood tests can check iron (ferritin), thyroid function and other levels where your history suggests it.
- Supplement only what you’re low in. Treat a documented deficiency rather than taking high-dose “hair vitamins.” Biotin in particular can interfere with some blood test results, so tell your doctor if you take it.
- Be gentle with your hair. Avoid tight hairstyles, harsh chemical treatments and excessive heat while shedding settles.
Topical minoxidil is sometimes discussed for shedding, but the evidence for telogen effluvium specifically is limited. Whether it makes sense for you depends on whether there’s also an underlying pattern of hair loss. See our overview of non-surgical hair restoration.
When should I see a doctor about hair loss on Ozempic?
Book an assessment if you notice:
- Patchy or bald spots rather than all-over shedding
- Itching, pain, redness or scaling on the scalp
- Shedding that lasts longer than about six months
- A receding hairline, thinning crown or widening part that isn’t recovering
- Other symptoms such as fatigue, feeling cold or changes in your periods, which can point to thyroid or iron problems
Dr. Bobby also works in hormone therapy and preventative care, so an assessment can consider your overall health, not just your scalp. The goal is a clear diagnosis and a game plan that supports your hair without getting in the way of your health goals.
Can I get a hair transplant while I’m on a GLP-1 medication?
Taking a GLP-1 medication doesn’t by itself rule out a hair transplant. But surgery isn’t a good idea while you’re actively shedding or still losing weight quickly. Hair surgeons generally want hair density to be stable before they plan a transplant. Otherwise it’s hard to judge your true pattern, your donor area, or how much of the thinning will recover on its own.
For most people, the sensible order is to let your weight and shedding stabilize, treat any deficiencies, and then reassess. If a transplant is still the right option, we can plan it around your long-term goals. Read more about what makes a good hair transplant candidate and how long hair transplants last.
Get your hair assessed in Calgary
If you’ve started a GLP-1 medication and your hair has changed, an assessment can tell you whether you’re dealing with temporary shedding, an underlying pattern, or both. Book a consultation with Dr. Bobby. Cosmetic hair restoration is not covered by the Alberta Health Care Insurance Plan, and some consultation and assessment services may not be covered either.
Frequently asked questions
Does Ozempic cause hair loss?
It can be associated with hair shedding, mostly because of rapid weight loss. Hair loss isn’t listed as a common side effect for Ozempic’s diabetes doses, but it was reported in about 3% of people on Wegovy, the higher-dose version used for weight loss, compared with about 1% on placebo.
Does Mounjaro or Zepbound cause hair loss?
In Zepbound trials, hair loss was reported in about 4% to 5% of people, compared with under 1% on placebo. All cases were mild or moderate, and it was linked to weight reduction and reported more often in women.
Will my hair grow back after Ozempic hair loss?
Usually, yes. Shedding from rapid weight loss is typically temporary. It tends to settle within three to six months once weight stabilizes, and fullness often returns within six to nine months. If it doesn’t, an assessment can check for other causes.
When does hair loss start on GLP-1 medications?
Shedding usually begins about two to four months after the trigger, so many people notice it a few months into their weight loss.
Should I stop my GLP-1 medication if my hair is falling out?
Not without talking to your prescriber. Shedding is usually temporary, and stopping a medication can affect your health goals. Your doctor can review your dose, nutrition and blood work first.
How much protein should I eat on Ozempic to protect my hair?
A 2025 nutrition advisory for people on GLP-1 therapy suggests a target of about 80 to 120 g of protein a day, and notes that 1.2 to 1.6 g per kilogram per day has been proposed during active weight loss. Your own needs depend on your health, so check with your doctor or dietitian.
Do biotin supplements help GLP-1 hair loss?
There’s no good evidence that biotin helps if you aren’t deficient, and it can interfere with some blood tests. It’s better to test for deficiencies such as low iron and treat what’s actually low.
Can I get a hair transplant while on Ozempic or Wegovy?
The medication itself isn’t a barrier, but surgery is best delayed until your weight is stable and shedding has settled, so your true hair loss pattern and donor area can be assessed accurately.
Is GLP-1 hair loss the same as male or female pattern baldness?
No. GLP-1 hair loss is usually temporary shedding (telogen effluvium) across the whole scalp. Pattern hair loss is genetic and gradual. Shedding can make an existing pattern more noticeable, which is why a scalp assessment helps.
References
- Health Canada. Wegovy (semaglutide injection) Product Monograph, December 2025. https://pdf.hres.ca/dpd_pm/00082777.PDF
- Health Canada. Zepbound (tirzepatide injection) Product Monograph, April 2026. https://pdf.hres.ca/dpd_pm/00084150.PDF
- U.S. Food and Drug Administration. Zepbound prescribing information, revised April 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806Orig1s050lbl.pdf
- U.S. Food and Drug Administration. Potential signals of serious risks identified by FAERS, July–September 2023 (alopecia, GLP-1 receptor agonists). https://www.fda.gov/drugs/fdas-adverse-event-reporting-system-faers/july-september-2023-potential-signals-serious-risksnew-safety-information-identified-fda-adverse
- Pedersen SD, et al. Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update. CMAJ. 2025;197(27):E797. https://www.cmaj.ca/content/197/27/E797
- American Academy of Dermatology. GLP-1 drugs and side effects. https://www.aad.org/public/everyday-care/skin-care-secrets/prevent-skin-problems/glp1-drugs-and-side-effects
- American Academy of Dermatology. Do you have hair loss or hair shedding? https://www.aad.org/public/diseases/hair-loss/insider/shedding
- Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity. Am J Clin Nutr. 2025;122:344–367. doi:10.1016/j.ajcnut.2025.04.023
- BMJ Group. GLP-1 diabetes drugs linked to increased risk of hair loss (2026). https://bmjgroup.com/glp-1-diabetes-drugs-linked-to-increased-risk-of-hair-loss/
- British Association of Dermatologists. Telogen effluvium patient information leaflet, October 2025. https://www.skinhealthinfo.org.uk/wp-content/uploads/2018/11/Telogen-effluvium-PIL-Oct-2025.pdf
- Increased incidence and risk of hair loss with glucagon-like peptide-1 receptor agonists: a real-world multicentre cohort study. EMJ Dermatology. 2025;13(1):52–54. https://www.emjreviews.com/dermatology/abstract/increased-incidence-and-risk-of-hair-loss-with-glucagon-like-peptide-1-receptor-agonists-a-real-world-multicentre-cohort-study-j030123/
